1. Volume 130, Issue 7, Pages 2189-2197 (June 2006)
Serum Proteome to Predict Virologic Response in Patients With Hepatitis C Treated by Pegylated Interferon Plus Ribavirin 
Valérie Paradis, Tarik Asselah, Delphine Dargere, Marie–Pierre Ripault, Michèle Martinot, Nathalie Boyer, Dominique Valla, Patrick Marcellin, Pierre Bedossa 
Gastroenterology 
Volume 130, Issue 7, Pages (June 2006)
DOI: /j.gastro
Copyright © 2006 American Gastroenterological Association Institute Terms and Conditions

2. Figure 1
Number of peaks that significantly changed in intensity between the beginning and the end of treatment according to genotype, stage of fibrosis, and grade of activity in the training group.
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2006 American Gastroenterological Association Institute Terms and Conditions

3. Figure 2
Variation in intensity of the cM32835 peak before beginning of treatment, at the end of treatment, and in the follow-up serum sample in the group of (A) sustained responders and (B) nonresponders in the training group.
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2006 American Gastroenterological Association Institute Terms and Conditions

4. Figure 3
Number of peaks that significantly changed in intensity between the beginning (SO) and end of treatment (SEOT) and between the end of treatment (SEOT) and follow-up (SEFU) in all patients, the group of sustained responders, and the group of nonresponders in the training group.
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2006 American Gastroenterological Association Institute Terms and Conditions

5. Figure 4
Box plot of peaks that distinguish the group of nonresponders from the group of sustained responders in the initial serum sample in the training cohort.
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2006 American Gastroenterological Association Institute Terms and Conditions